Ocular implant with therapeutic agents and methods thereof

US9066782B2 · kind B2 · utility

Assignee

• Dose Medical Corporation · US

Inventors

• Hosheng Tu · Newport Beach, US
• Barbara A. Niksch · Laguna Niguel, US
• David S. Haffner · Mission Viejo, US
• Gregory T. Smedley · Aliso Viejo, US
• Olav B. Bergheim · Laguna Hills, US
• Morteza Gharib · San Marino, US
• Richard A. Hill · Irvine, US
• Thomas W. Burns · Dana Point, US

Key dates

• Filing date: Dec 17, 2012
• Grant date: Jun 30, 2015
• Expiry date: Dec 17, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61L2430/16
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following implantation. A therapeutic agent is eluted from the implant into the eye. Desirably, the release of the therapeutic agent from the implant is controlled. The controlled release of the therapeutic agent can be at a chosen rate and/or for a selected duration which can be episodic or periodic. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension.